Substance
OFATUMUMAB
Global reference: every product and company linked to this substance.
- cas: 679818-59-8
- ncit: C66952
- pubchem_cid: 6918251
- rxnorm: 712566
- unii: M95KG522R0
ARZERRA · GSK-1841157 · GSK1841157 · GSKI841157 · HUMAX-CD20 2F2 · HUMAX-CD20, 2F2 · HUMAX-CD20-2F2 · ofatumumab [INN] · OFATUMUMAB [JAN] · OFATUMUMAB [USAN] · Ofatumumab [WHO-DD]
Revenue by product (0)
No revenue reported for this substance in loaded filings.
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (3)
- ARZERRA · NOVARTIS AG COMMON STOCK
- KESIMPTA · NOVARTIS AG COMMON STOCK
- KESIMPTA · NOVARTIS AG COMMON STOCK